Brought to you by 
Sequenom nets $48mm through private placement
13 May 2010
Executive Summary
Sequenom Inc. (molecular diagnostics with a focus on prenatal testing) has netted $48mm through the private placement of 12.4mm common shares at $4.15 each (a 28% discount). Jefferies & Co. and Lazard Capital Markets were the placement agents.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sequenom nets $48mm through private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice